U.S. Residential REITs Stock News

Visa stock has delivered a 60.7% return over the past five years, yet its valuation signals are split. The Excess Returns intrinsic value estimate points to some upside, while traditional market multiples lean the other way and the broader checks do not flag Visa as a clear bargain. Over five years Visa has returned 60.7%. This puts the focus on whether the current share price already reflects much of that progress. Recent moves into stablecoin payment rails and AI driven fraud prevention...

Alpha Tau Medical earnings put recent clinical progress in context Alpha Tau Medical (NasdaqCM:DRTS) has paired a series of high profile clinical and partnership milestones with fresh half year results that show a wider net loss and higher loss per share. The company reported a net loss of US$68.75 million for the half year to June 30, 2026, compared with a loss of US$18.81 million a year earlier. Basic and diluted loss per share from continuing operations were both US$0.76, compared with...

In the past week, Intuitive Surgical reported fiscal Q2 2026 results that exceeded revenue and adjusted EPS forecasts, while also updating its bylaws to align shareholder voting and nomination rules with recent SEC universal proxy requirements. Despite solid global procedure expansion across da Vinci and Ion systems, investors focused on moderating U.S. procedure growth and tighter governance procedures that could shape future shareholder influence and board elections. We’ll now examine how...

Meta Platforms (NasdaqGS:META) has been ordered by Chinese regulators to unwind its US$2b acquisition of AI agent startup Manus, affecting its AI plans in Asia. The forced reversal removes Manus from Meta's AI portfolio at a time when global tech companies are competing aggressively on AI agent capabilities. Separately, a U.S. federal court has allowed more than 3,000 addiction related lawsuits targeting Meta's social media platforms to move forward. The combination of regulatory pressure in...

Why ACADIA Pharmaceuticals Stock Is Back in Focus After Guidance Update ACADIA Pharmaceuticals (ACAD) put its stock firmly on investors’ radar after raising 2026 earnings guidance and reporting second quarter results that showed higher revenue and net income compared with a year earlier. The company now expects 2026 revenue between US$1.24b and US$1.30b, with NUPLAZID projected at US$760 million to US$790 million and DAYBUE at US$480 million to US$510 million. These updated figures illustrate...

Central banks are talking tougher on inflation, growth forecasts are being cut, and energy markets remain volatile, which puts the spotlight squarely on large energy stocks exposed to these pressures. For investors, this mix of risk and potential resilience can reshape how you think about where to put new money or what to hold. This article breaks down 3 energy stocks affected by the recent news and explains why each may warrant a closer look now. The three stocks covered below are just a...

Bio-Rad Laboratories (BIO) has moved into focus after its second quarter 2026 earnings and fresh guidance, which combined a slight overall revenue decline with firmer contributions from several international markets. See our latest analysis for Bio-Rad Laboratories. The recent guidance and international revenue patterns arrived alongside a sharp shift in sentiment around Bio-Rad Laboratories, with a 46.30% 90 day share price return and a 29.66% 1 year total shareholder return contrasting with...

In early August 2026, The Timken Company reported second-quarter results showing sales rising to US$1,260.9 million from US$1,173.4 million a year earlier, while net income fell to US$28.9 million from US$78.5 million, alongside confirming a US$0.36 quarterly dividend and completing a US$47.97 million share repurchase program. At the same time, Timken raised its 2026 earnings and revenue outlook and reworked its senior leadership team to support its Elevate to Outperform plan, signaling a...

Lockheed Martin stock has delivered an 89.2% return over the past 5 years, yet current valuation work suggests the shares may still trade below an estimate of intrinsic value based on a Discounted Cash Flow (DCF) model and earnings multiples that both screen as undervalued. That 89.2% 5 year gain means existing shareholders have already seen a strong payoff, so new buyers need to weigh what is already reflected in the price. A multiyear PAC 3 missile production contract and ongoing missile...

In early August 2026, Curio announced a Memorandum of Understanding with NuScale Power and Framatome to assess an integrated, closed-loop nuclear fuel solution using Curio’s NuCycle recycling technology to support domestic and international nuclear fuel supply chains. This collaboration highlights growing industry interest in pairing NuScale’s small modular reactor platform with advanced fuel-cycle technologies that aim to reduce waste volumes and strengthen long-term nuclear energy...

In early August 2026, Haemonetics Corporation reported first‑quarter sales of US$339.38 million versus US$321.39 million a year earlier, with diluted earnings per share from continuing operations rising to US$0.72, and also filed a US$391.25 million shelf registration for 4,680,000 common shares tied to an ESOP-related offering. A new Emory University study, published with Haemonetics funding, reinforced the safety and efficiency profile of the VASCADE MVP XL venous vascular closure system...

In recent weeks, Science Applications International Corporation (SAIC) secured a US$400 million recompete contract with a U.S. intelligence agency and a new US$70 million U.S. Navy radar task order, while also appointing seasoned executives David Benson and David Cush to its expanded 12-member Board and key committees. These awards and board changes reinforce SAIC’s role in complex defense and intelligence programs, while adding deep financial, capital markets, and large-scale operational...

Ichor Holdings, Ltd. reported second-quarter 2026 results showing sales of US$294.78 million and net income of US$0.998 million, a shift from a loss a year earlier, and issued third-quarter revenue guidance of US$315 million to US$345 million with expected GAAP diluted EPS between US$0.25 and US$0.35. These results indicate improved profitability and higher sales compared with the prior year period, while the company’s forward guidance offers investors clearer expectations around revenue and...

With investors glued to upcoming US inflation data, oil price swings and firm Treasury yields, high dividend yield stocks are drawing fresh attention from anyone looking for steadier income while markets debate the Federal Reserve’s next move in September. This article looks at how those macro forces link back to company fundamentals and payout strength. You will see three stocks from the screener that appear positively exposed to the current backdrop. The three stocks highlighted below are...

Apnimed, Inc (NasdaqGS:APMD) has been added to the NASDAQ Composite Index following its recent IPO. The addition comes soon after Apnimed filed a shelf registration statement, signaling further corporate funding flexibility. Index inclusion typically draws attention from index-tracking funds and can affect trading volumes and liquidity. This kind of index move, combined with fresh IPO activity, points to a wider group of stocks that may be worth a closer look through 51 high quality...

Why nVent Electric’s latest earnings and expansion matter for investors nVent Electric (NVT) is in focus after reporting second quarter 2026 earnings, along with new manufacturing expansion plans for its data center liquid cooling business, tied to AI and high-performance computing demand. See our latest analysis for nVent Electric. The latest earnings release and data center expansion news come on top of strong momentum in nVent Electric’s stock, with a year to date share price return of...

Applied Optoelectronics, Inc. has reported its past second-quarter 2026 results, with sales rising to US$191.92 million from US$102.95 million a year earlier, while net loss widened to US$22.78 million and loss per share from continuing operations increased to US$0.28. Despite higher sales for both the quarter and first half of 2026, the company’s net losses and per-share losses also grew, highlighting the trade-off between rapid top-line expansion and the costs required to support that...

DXP Enterprises recently reported its Q2 2026 results, with sales rising to US$576.46 million and net income to US$28.71 million, alongside higher basic and diluted earnings per share from continuing operations compared with a year earlier. An interesting detail is that growth in the Innovative Pumping Solutions and Water platforms, supported by recent acquisitions, played a major role in lifting both revenue and earnings for the quarter and first half of 2026. With Q2 earnings buoyed by...

Upstart Holdings recently reported second-quarter 2026 results showing higher net income of US$16.54 million and reiterated its full-year 2026 revenue guidance of about US$1.40 billion. At the same time, Upstart expanded its funding reach through a new multi-year forward-flow agreement under which Castlelake-managed funds may buy up to US$4.00 billions of consumer loans originated on its platform over up to 24 months. Next, we’ll examine how reaffirmed revenue guidance combined with the...

Rexford Industrial Realty stock sits in a tricky spot for valuation minded investors. The Discounted Cash Flow (DCF) intrinsic value estimate lines up fairly closely with the current share price, while the market multiple view suggests the stock is trading at a premium and long term returns have been weak. Rexford Industrial Realty shareholders have seen the stock decline about 31% over the past 5 years, which raises questions about how much long term value has actually been created. The...

WaFd stock reaction and recent performance snapshot WaFd (WAFD) did not have a specific news event driving today’s move, yet the stock advanced to a last close of US$38.06, with 1 day and 7 day returns of 2.0% and 1.0%. Over the past month the share price was roughly flat with a slight decline of 0.1%, while the past 3 months show a 10.0% gain and the 1 year total return stands at 29.1%. See our latest analysis for WaFd. At around US$38.06, WaFd’s recent share price strength over the past...

Everest Group stock moves after mixed quarter and fresh shelf registration Everest Group (NYSE:EG) is back in focus after its second quarter 2026 results showed lower revenue and net income compared with a year earlier, alongside a new shelf registration for common stock. See our latest analysis for Everest Group. Everest Group shares trade at US$365.70 after a muted reaction to the second quarter earnings update, with a 90 day share price return of 5.1% and a 1 year total shareholder return...

FIFA’s leadership turmoil and talk of boycotts has put the business of global football under an uncomfortable spotlight, from billion dollar media rights to sponsorships tied to future World Cups. That disruption risk also creates an opening for investors watching sports media and broadcasting stocks exposed to this news. This article breaks down how three stocks from our screener are positioned, so you can judge whether the story fits your portfolio. The stocks covered below are just a...

With the July CPI release putting Federal Reserve rate expectations on a knife edge, interest rate sensitive U.S. REITs suddenly sit at the heart of the story rather than the sidelines. A softer inflation print could support rate relief hopes, while a hotter reading could do the opposite. This article walks through three REIT stocks exposed to that CPI outcome so you can see where opportunity and risk may be building right now. The three REITs below are just a starting sample, since the full...